Your browser doesn't support javascript.
loading
Nfkb2 variants reveal a p100-degradation threshold that defines autoimmune susceptibility.
Wirasinha, Rushika C; Davies, Ainsley R; Srivastava, Monika; Sheridan, Julie M; Sng, Xavier Y X; Delmonte, Ottavia M; Dobbs, Kerry; Loh, Khai L; Miosge, Lisa A; Lee, Cindy Eunhee; Chand, Rochna; Chan, Anna; Yap, Jin Yan; Keller, Michael D; Chen, Karin; Rossjohn, Jamie; La Gruta, Nicole L; Vinuesa, Carola G; Reid, Hugh H; Lionakis, Michail S; Notarangelo, Luigi D; Gray, Daniel H D; Goodnow, Christopher C; Cook, Matthew C; Daley, Stephen R.
Afiliação
  • Wirasinha RC; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.
  • Davies AR; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
  • Srivastava M; Translational Research Unit, Department of Immunology, The Canberra Hospital, Canberra, Australia.
  • Sheridan JM; Centre for Personalised Immunology (NHMRC Centre of Research Excellence), John Curtin School of Medical Research, Australian National University, Canberra, Australia.
  • Sng XYX; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
  • Delmonte OM; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
  • Dobbs K; Department of Medical Biology, University of Melbourne, Melbourne, Australia.
  • Loh KL; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.
  • Miosge LA; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Lee CE; Laboratory of Clinical Immunology and Microbiology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD.
  • Chand R; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.
  • Chan A; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
  • Yap JY; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
  • Keller MD; Translational Research Unit, Department of Immunology, The Canberra Hospital, Canberra, Australia.
  • Chen K; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
  • Rossjohn J; Translational Research Unit, Department of Immunology, The Canberra Hospital, Canberra, Australia.
  • La Gruta NL; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.
  • Vinuesa CG; Department of Immunology and Infectious Disease, John Curtin School of Medical Research, Australian National University, Canberra, Australia.
  • Reid HH; Division of Allergy and Immunology, Children's National Medical Center, Washington, DC.
  • Lionakis MS; Department of Pediatrics, University of Utah, Salt Lake City, UT.
  • Notarangelo LD; Department of Pediatrics, Seattle Children's Hospital, University of Washington School of Medicine, Seattle, WA.
  • Gray DHD; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.
  • Goodnow CC; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Australia.
  • Cook MC; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, UK.
  • Daley SR; Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, Australia.
J Exp Med ; 218(2)2021 02 01.
Article em En | MEDLINE | ID: mdl-33107914
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoimunidade / Subunidade p52 de NF-kappa B Limite: Animals / Female / Humans / Male Idioma: En Revista: J Exp Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Autoimunidade / Subunidade p52 de NF-kappa B Limite: Animals / Female / Humans / Male Idioma: En Revista: J Exp Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Austrália